NCT03539185

Brief Summary

The airway management is a vital act in anesthesia. The gold standard technique for planned very difficult intubation is nasotracheal fiberoptic intubation. The success rate with this procedure is 98.8%. However, learning this technique is difficult and it's considered uncomfortable by patients and practitioners. The Airtraq® videolaryngoscope is commonly used for difficult orotracheal intubation. Cases of awake intubation by Airtraq® have been described. Furthermore, the French Society of Anesthesia-Resuscitation, in its last formalized expert recommendations (2017) on difficult intubation, proposes the use of video laryngoscopes as an alternative to the fiberoptic bronchoscope. We propose a non-inferiority study evaluating the use of Airtraq® for the realization of a awake intubation compared to the gold standard (fiberoptic bronchoscope). This prospective randomized study should include 78 patients in two groups. The purpose of this study is to improve the comfort of patient and practitioner during an awake tracheal intubation, to facilitate the learning of the technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2020

Completed
Last Updated

October 19, 2020

Status Verified

May 1, 2020

Enrollment Period

2 years

First QC Date

May 12, 2018

Last Update Submit

October 14, 2020

Conditions

Keywords

AirtraqFiberopticAwakeTracheal intubationlaryngeal nerve blockssedationremifentanil

Outcome Measures

Primary Outcomes (1)

  • Success of orotracheal or nasotracheal intubation.

    Defined by the visualization of the tube into the trachea through vocal cords and by the appearance of the capnogram

    1 day

Secondary Outcomes (5)

  • Length of the proceedings

    1 day

  • Rate of occurrence of adverse events

    1 day

  • Patient satisfaction score

    1 day

  • Operator satisfaction score

    1 day

  • Number of intubation attempts

    1 day

Study Arms (2)

Airtraq

ACTIVE COMPARATOR

Awake tracheal intubation using airtraq videolaryngoscope.

Device: Videolaryngoscope Airtraq

Fiberoptic

ACTIVE COMPARATOR

Awake nasotracheal tracheal intubation using flexible fiberoptic bronchoscope.

Device: Fiberoptic bronchoscope

Interventions

Awake orotracheal intubation with laryngeal nerve block and remifentanil sedation

Airtraq

Awake nasotracheal intubation with laryngeal nerve block and remifentanil sedation

Fiberoptic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Formal indication of awake intubation or patient with two criteria of difficult intubation and ventilation
  • Major patient
  • Patient able to understand oral and written information

You may not qualify if:

  • Mouth opening (inter-incisor distance) \<16 mm does not allow insertion of the Airtraq® videolaryngoscope
  • Surgery requires nasotracheal intubation
  • Loco-regional anesthesia of larynx impossible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Caen

Caen, Normandy, 14000, France

Location

Related Publications (9)

  • Collins SR, Blank RS. Fiberoptic intubation: an overview and update. Respir Care. 2014 Jun;59(6):865-78; discussion 878-80. doi: 10.4187/respcare.03012.

  • Pintaric TS. UPPER AIRWAY BLOCKS FOR AWAKE DIFFICULT AIRWAY MANAGEMENT. Acta Clin Croat. 2016 Mar;55 Suppl 1:85-9.

  • Law JA, Morris IR, Brousseau PA, de la Ronde S, Milne AD. The incidence, success rate, and complications of awake tracheal intubation in 1,554 patients over 12 years: an historical cohort study. Can J Anaesth. 2015 Jul;62(7):736-44. doi: 10.1007/s12630-015-0387-y. Epub 2015 Apr 24.

  • Law JA, Morris IR, Milne AD. The complications of awake tracheal intubation. Can J Anaesth. 2015 Sep;62(9):1023. doi: 10.1007/s12630-015-0402-3. Epub 2015 May 12. No abstract available.

  • Allan AG. Reluctance of anaesthetists to perform awake intubation. Anaesthesia. 2004 Apr;59(4):413. doi: 10.1111/j.1365-2044.2004.03729.x. No abstract available.

  • Xu YC, Xue FS, Luo MP, Yang QY, Liao X, Liu Y, Zhang YM. Median effective dose of remifentanil for awake laryngoscopy and intubation. Chin Med J (Engl). 2009 Jul 5;122(13):1507-12.

  • Dawson AJ, Marsland C, Baker P, Anderson BJ. Fibreoptic intubation skills among anaesthetists in New Zealand. Anaesth Intensive Care. 2005 Dec;33(6):777-83. doi: 10.1177/0310057X0503300613.

  • Dimitriou VK, Zogogiannis ID, Liotiri DG. Awake tracheal intubation using the Airtraq laryngoscope: a case series. Acta Anaesthesiol Scand. 2009 Aug;53(7):964-7. doi: 10.1111/j.1399-6576.2009.02012.x. Epub 2009 Jun 3.

  • Suzuki A, Toyama Y, Iwasaki H, Henderson J. Airtraq for awake tracheal intubation. Anaesthesia. 2007 Jul;62(7):746-7. doi: 10.1111/j.1365-2044.2007.05155.x. No abstract available.

Study Officials

  • Alexandre FRUGIER, Résident

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR
  • Hervé KAMGA, Dr

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Non-inferiority trial. Alpha risk de 2,5%, Power 90 %
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2018

First Posted

May 29, 2018

Study Start

June 1, 2018

Primary Completion

May 18, 2020

Study Completion

May 18, 2020

Last Updated

October 19, 2020

Record last verified: 2020-05

Locations